Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SCT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02504619
What this trial is testing

Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia
Gamida Cell ltd 1
Testing effectiveness (Phase 2)Study completedNCT01590628
What this trial is testing

Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell Disease & Thalassemia
Gamida Cell ltd 16
Large-scale testing (Phase 3)Study completedNCT00065962
What this trial is testing

Secretin for the Treatment of Autism

Who this might be right for
Autism
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 85
Not applicableStudy completedNCT07329452
What this trial is testing

Menu to Meal (M2M) Menu Labeling Intervention Study

Who this might be right for
Behavior, Eating
Texas A&M University 242
Large-scale testing (Phase 3)Study completedNCT03290846
What this trial is testing

Secretin Activates Human Brown Fat and Induces Satiation.

Who this might be right for
Obesity
Turku University Hospital 23
Testing effectiveness (Phase 2)Study completedNCT00578942
What this trial is testing

Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 48
Not applicableStudy completedNCT03204721
What this trial is testing

Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis

Who this might be right for
Graft-Versus-Host Disease
Oslo University Hospital 158
Not applicableStudy completedNCT04386928
What this trial is testing

ALLO-SCT in Elderly Patients With Hematological Disease

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 1,996
Large-scale testing (Phase 3)UnknownNCT00002989
What this trial is testing

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
European Organisation for Research and Treatment of Cancer - EORTC 207
Not applicableStudy completedNCT01997476
What this trial is testing

EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease

Who this might be right for
Pancreatic Disease
Indiana University 166
Early research (Phase 1)WithdrawnNCT00062543
What this trial is testing

Hepatic Artery Infusion of CD34+ Cells

Who this might be right for
Stem Cell TransplantationLiver Diseases
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02635035
What this trial is testing

Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

Who this might be right for
Attention Deficit DisorderAttention Deficit Hyperactivity Disorder
NYU Langone Health 38
Not applicableStudy completedNCT00579917
What this trial is testing

Behavioral Intervention For BMT/SCT Survivors

Who this might be right for
Hodgkin's DiseaseLeukemiaMultiple Myeloma+1 more
Memorial Sloan Kettering Cancer Center 133
Not applicableWithdrawnNCT02812082
What this trial is testing

Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant

Who this might be right for
Allo-SCT PatientsAdult Allo-SCT Survivor
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02701673
What this trial is testing

Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00330018
What this trial is testing

Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

Who this might be right for
Bone Marrow TransplantationCytomegalovirus
Hadassah Medical Organization 40
Testing effectiveness (Phase 2)Study completedNCT02258815
What this trial is testing

CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma Recurrent
University Children's Hospital Tuebingen 35
Not applicableUnknownNCT01891877
What this trial is testing

Sickle Cell Trait in Football Players

Who this might be right for
Sickle Cell Trait
University of South Florida 20
Testing effectiveness (Phase 2)Ended earlyNCT00005984
What this trial is testing

Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 22
Early research (Phase 1)Study completedNCT04473911
What this trial is testing

Haplo Peripheral Blood Sct In GVHD Prevention

Who this might be right for
GVHDAMLALL+13 more
Zachariah Michael DeFilipp 25
Next Page